21 Invest-backed ProductLife Group completed the acquisition of Axpharma from Galiena Capital.

21 Invest-backed ProductLife Group, a specialist provider of regulatory and compliance services for the life sciences industry completed the acquisition of Axpharma, a pharmacovigilance service provider in Europe, from Galiena Capital, a private equity firm. Financial terms were not disclosed. “Our strategic priority is to reinforce PLG’s ability to address the needs of today’s biopharma and medical product industry, drawing upon decades of experience in management of scientific and regulatory aspects of medicine. The merger of PLG and Axpharma offers tremendous potential to further invest in automation and artificial intelligence, as part of the aim to offer to our clients reliable, innovative, and cost-effective solutions that are always one step ahead of what the industry expects," Xavier Duburcq, PLG CEO.